GW Pharmaceuticals plc’s $7.2 Billion Acquisition by Jazz Pharmaceuticals plc
February 03, 2021
On February 3, 2021, GW Pharmaceuticals plc (“GW”) and Jazz Pharmaceuticals plc (“Jazz”) announced that they have entered into a definitive agreement for Jazz to acquire GW, a global leader in developing, manufacturing and commercializing novel, regulatory approved therapeutics from its proprietary cannabinoid product platform to address a broad range of diseases for $220.00 per American Depositary Shares (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares for a total consideration of $7.2 billion. Cravath is representing GW in connection with the transaction.
The Cravath team is led by partner George F. Schoen and includes associates William F. Roegge, Dana Leshem and Fay E. Krewer on M&A matters; partner Jonathan J. Katz and associates Daniel P. Herrmann and Dixing Tang on executive compensation and benefits matters; partners Stephen M. Kessing, Michael E. Mariani and Matthew M. Kelly and associates Joseph A. Marshall and Carol S. Lin on financing matters; partner J. Leonard Teti II on tax matters; partner David J. Kappos and associate Daniel J. Etcovitch on intellectual property matters; partner Margaret T. Segall and practice area attorney Nicole M. Peles on regulatory matters; senior attorney Annmarie M. Terraciano on environmental matters; and practice area attorney Brian M. Budnick on real estate matters. Armin Hoss also worked on M&A matters; Sonia Katharani‑Khan also worked on tax matters; Laura S. Lee also worked on executive compensation and benefits matters; and Pedraam Mirzanian also worked on intellectual property matters.
Related Practices & Industries
People
- Photo
-
-
LL.M., 2013, New York University School of Law
-
J.D., 2007, Benjamin N. Cardozo School of LawOrder of the Coif, Dean's Distinguished Scholar, summa cum laude
-
B.S., 2003, Cornell University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, Duke Law SchoolOrder of the Coif, magna cum laude
-
M.B.A., 2001, University of Southern California
-
B.S., 1995, Miami University of Ohio
- New York
Education
Admitted In
- Photo
-
-
J.D., 2009, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.B.A., 2009, Columbia University
-
B.A., 2004, Tufts UniversityPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2013, New York University School of LawJohn Norton Pomeroy Scholar; Benjamin Butler Scholar; Order of the Coif, magna cum laude
-
A.B., 2006, Dartmouth Collegecum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
- Photo
-
-
J.D., 2008, Harvard Law Schoolcum laude
-
A.B., 2003, Harvard Collegemagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2010, New York University School of Lawcum laude
-
A.B., 2007, Dartmouth College
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Wisconsin - Madison
-
B.A., 1989, Wellesley Collegecum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2011, Benjamin N. Cardozo School of Lawcum laude
-
B.A., 2006, University of Virginia
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
January 19, 2021
binderholz Group’s Acquisition of Substantially All the Assets of Klausner Lumber Two Through a 363 Sale
On December 10, 2020, the Austria‑based binderholz Group, a leading European company for solid wood products and innovative building solutions, announced it had entered into a definitive agreement to purchase substantially all the assets of the North Carolina‑based sawmill operator Klausner Lumber Two, LLC after prevailing in an auction held on December 10, 2020. Klausner Lumber Two, LLC is currently in Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. The sale, which was made pursuant to Section 363 of the United States Bankruptcy Code, was approved by the court on December 17, 2020 and closed on January 8, 2021. Cravath is representing binderholz Group in connection with the transaction.
Deals & Cases
January 12, 2021
IBM’s Acquisition of 7Summits
On January 11, 2021, IBM announced that it has acquired 7Summits, a leading Salesforce consultancy with more than a decade of delivering digital experiences across industries. The acquisition extends IBM’s portfolio of Salesforce services and experience design capabilities and further advances IBM’s hybrid cloud and AI strategy. Cravath represented IBM in connection with the transaction.
Deals & Cases
January 11, 2021
Roku Acquires Quibi’s Global Content Distribution Rights
On January 8, 2021, Roku, Inc. announced that The Roku Channel will become the exclusive place to stream more than 75 premium shows and documentaries that Quibi, a streaming platform designed to deliver short‑form content, created in conjunction with Hollywood’s leading studios and production companies. Roku acquired the exclusive global distribution rights to Quibi’s award‑winning shows and will make the content available for free on an ad‑supported basis in 2021 to all Roku users. Following an internal restructuring by Quibi, Roku acquired Quibi Holdings, LLC, the company that holds all of Quibi’s content distribution rights. Cravath is representing Quibi in connection with the transaction.
Deals & Cases
January 06, 2021
AmerisourceBergen’s $6.5 Billion Acquisition of Alliance Healthcare Businesses from Walgreens Boots Alliance
On January 6, 2021, AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. In addition, the companies have agreed to extend and expand their commercial agreements through 2029 to drive incremental growth. Cravath is representing AmerisourceBergen in connection with the transaction.
